Formal contacts with WHO on this immunogen, developed by the Center for Genetic Engineering and Biotechnology (CIGB), began in March.
https://www.google.com/url?rct=j&sa=t&url=http://en.escambray.cu/2022/cuba-has-abdala-vaccine-dossier-ready-for-who/&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AOvVaw0zJX4LOdV96TKD8F0PJUWn
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.